Human Pharmaceutical Portfolio

Lapahope 250 mg Tablet 120N

Product information from the Times Medicament supplied portfolio. Contact our export team to confirm current sourcing options, market requirements and commercial availability.

Molecule / StrengthLapatinib 250 mg
ManufacturerGlenmark Pharmaceuticals Ltd
CategoryAnti-Cancer
This product is listed in the supplied Times Medicament unregistered product portfolio. Listing does not by itself confirm registration, licensing or availability in any specific country. Market-specific confirmation is required.